新型無針鼻噴劑獲批用於治療兒童過敏症
New Needle-Free Nasal Spray Approved for Childhood Allergies
Updated at: June 13, 2026 at 06:45 AM
對於數百萬管理嚴重過敏的家庭來說，緊急「EpiPen」長期以來一直是壓力的來源。
For millions of families managing severe allergies, the emergency "EpiPen" has long been a source of stress.
許多家長和患者害怕針頭，導致治療出現危險的延誤。
Many parents and patients fear needles, leading to dangerous delays in treatment.
幸運的是，一項醫學突破正在改變過敏照護的格局：neffy，這是首款無針腎上腺素鼻噴劑。
Fortunately, a medical breakthrough is changing the landscape of allergy care: neffy, the first needle-free epinephrine nasal spray.
該裝置已獲得美國食品藥物管理局（FDA）和英國藥品及保健品管理局（MHRA）的批准，能將救命的腎上腺素直接輸送到鼻孔中，即使患者鼻塞也能使用。
Approved by the FDA and the MHRA, this pocket-sized device delivers life-saving epinephrine directly into the nostril, even if the patient is congested.
重要的是，這是一種緊急救援藥物，這意味著使用後仍必須尋求即時的醫療護理。
Importantly, this is an emergency rescue medication, meaning that after use, one must still seek immediate medical attention.
隨著像neffyinSchools這類推廣普及性的計畫出現，這項創新提供了一種更舒適、較不具威脅性的方式來管理威脅生命的過敏反應，證明了救命技術既可以是有效的，也可以是平易近人的。
With programs like neffyinSchools promoting accessibility, this innovation offers a more comfortable, less intimidating way to manage life-threatening allergic reactions, proving that life-saving technology can be both effective and approachable.
